Stock UPC UNIVERSE PHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up

Company Universe Pharmaceuticals INC

Equities

UPC

KYG9442G1120

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-05-20 EDT 		5-day change 1st Jan Change
2.33 USD -10.04% Intraday chart for Universe Pharmaceuticals INC -0.21% +15.92%
04-15 Top Premarket Decliners MT
01-30 Universe Pharmaceuticals INC Reports Earnings Results for the Full Year Ended September 30, 2023 CI

Business Summary

Universe Pharmaceuticals Inc is a China-based holding company mainly engaged in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (TCMD) products targeting the elderly. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The Company mainly conducts its businesses within the Chinese market.

Number of employees: 225

Sales per Business

USD in Million2022Weight2023Weight Delta
Traditional Chinese Medicine Derivatives
100.0 %
- - 32 100.0 % -

Sales per region

USD in Million2022Weight2023Weight Delta
China
100.0 %
40 100.0 % 32 100.0 % -19.52%

Managers

Managers TitleAgeSince
Gang Lai CEO
 Chief Executive Officer 56 -
Lin Yang DFI
 Director of Finance/CFO 48 -
Baochang Liu COO
 Chief Operating Officer 44 21-11-30

Members of the board

Members of the board TitleAgeSince
Gang Lai CEO
 Chief Executive Officer 56 -
Lin Yang DFI
 Director of Finance/CFO 48 -
Jiawen Pang BRD
 Director/Board Member 57 21-02-28
Ding Zheng BRD
 Director/Board Member 47 21-02-28
Yong Ping Yu BRD
 Director/Board Member 53 23-05-02

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,645,974 1,565,974 ( 42.95 %) 0 42.95 %

Shareholders

NameEquities%Valuation
Gang Lai
57.05 %
2,080,000 57.05 % 5 M $
UBS Securities LLC
0.0299 %
1,089 0.0299 % 2 516 $
Acadian Asset Management LLC
0.008228 %
300 0.008228 % 693 $

Company contact information

Universe Pharmaceuticals, Inc.

265 Jingjiu Avenue Jinggangshan

343100, Ji'an

+

http://www.universe-pharmacy.com
address Universe Pharmaceuticals INC(UPC)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Alternative Medicine

Sales per Business

Sector Alternative Medicine

1st Jan change Capi.
UNIVERSE PHARMACEUTICALS INC Stock Universe Pharmaceuticals INC
+15.92% 9.39M
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+41.06% 6.26B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-15.95% 4.49B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+6.36% 3.29B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-11.34% 3.12B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-3.12% 2.5B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+45.41% 1.94B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-7.74% 1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
-0.67% 1.63B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-11.32% 1.56B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. UPC Stock
  4. Company Universe Pharmaceuticals INC
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW